Zacks Small Cap Research – SNGX: Updated IIS Data Shows 75% Response Rate and Three Complete Responses… – Go Health Pro
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Interim Data from IIS Study Shows 75% Response Rate and Three Complete Responses On April 14, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced interim data from the ongoing, open label, investigator-initiated study (IIS) of HyBryte (synthetic hypericin) treatment for up to 54 weeks in … Read more